Tisagenlecleucel in Non-Hodgkin Lymphoma: The Restricted Mean Survival Time as a Tool for Estimating Progression-Free Life Expectancy Better than the Median
Marco Chiumente, Daniele Mengato, Andrea Messori
Topics & Concepts
Life expectancyHodgkin lymphomaProgression-free survivalLymphomaMedicineOncologySurvival analysisInternal medicineOverall survivalPopulationEnvironmental healthCAR-T cell therapy research